Trade RGC stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Regencell Bioscience Holdings Limited (RGC) is trading at US$5.92, up 2.25% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$2.62B. Over the past 52 weeks, RGC has traded between US$4.51 and US$69.00. On Syfe you can trade RGC with $0 commission and add it to your watchlist.
| Previous close | US$5.79 |
|---|---|
| Market cap | US$2.62B |
| 52-week range | US$4.51 – US$69.00 |
| Volume | 112.83K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.
Year: 2021
Regencell Bioscience Holdings Limited (RGC) stock is trading at US$5.92, +2.25% from the previous close of US$5.79.
The market cap for Regencell Bioscience Holdings Limited (RGC) stock is approximately US$2.62B.
The 52-week high for Regencell Bioscience Holdings Limited (RGC) stock is US$69.00.
The 52-week low for Regencell Bioscience Holdings Limited (RGC) stock is US$4.51.
Regencell Bioscience Holdings Limited (RGC) does not currently pay a dividend.
Stay on top of RGC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
